Byetta Prescription in Sherman, Texas at DFWPMA

Looking for a Byetta prescription in Sherman, Texas? Byetta (exenatide) is a prescription GLP-1 medication used to treat type 2 diabetes. It requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can lead to serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology and primary care providers conduct comprehensive evaluations of diabetes, metabolic health, kidney function, medical history, and treatment risks to determine whether Byetta is safe and appropriate for each patient.

DFWPMA offers Byetta prescription evaluations in Sherman and can prescribe Byetta or an appropriate exenatide alternative to eligible patients when medically appropriate and available. Byetta is FDA-approved to improve blood sugar control in adults with type 2 diabetes. Unlike weekly GLP-1 medications, Byetta is administered twice daily before meals.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.
Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for a Byetta Prescription in Sherman, Texas?

DFW Physicians Medical Associates provides Byetta prescription evaluations in Sherman through providers experienced in endocrinology, diabetes management, metabolic disorders, and chronic disease care. Our multispecialty approach supports individualized treatment decisions, medication safety, and ongoing medical supervision.

Patients seeking a Byetta prescription at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology and primary care providers experienced in diabetes management, metabolic health, and medication evaluations.
  • Comprehensive Eligibility Assessment: Reviewing diabetes status, medical history, current medications, kidney function, and potential contraindications before prescribing Byetta.
  • Diabetes and Metabolic Health Evaluation: Assessing blood glucose, hemoglobin A1c, kidney function, and other relevant metabolic indicators.
  • Individualized Prescription Decisions: Developing treatment recommendations according to diabetes goals, medication history, clinical risks, and overall health.
  • Medication Safety Screening: Evaluating pancreatitis history, kidney disease, gastrointestinal disorders, medication interactions, and other relevant precautions.
  • Twice-Daily Injection Management: Providing guidance on Byetta administration before meals, dose adjustments, injection technique, and medication tolerance.
  • Long-Term Diabetes Management: Monitoring blood sugar control, treatment effectiveness, kidney health, and related chronic conditions.
  • Coordinated Multispecialty Care: Connecting patients with additional medical and behavioral health services when comprehensive diabetes-related support is needed.

Byetta is not appropriate for every patient with type 2 diabetes. Prescribing decisions require evaluating glycemic control, kidney function, potential adverse effects, contraindications, medication availability, and alternative diabetes treatments.

At DFWPMA Sherman, comprehensive medical evaluation and individualized treatment planning help determine whether Byetta is an appropriate diabetes medication.

Schedule an appointment with DFWPMA Sherman to discuss Byetta prescription eligibility and your diabetes treatment options.

Meet Our Byetta Prescription Providers in Sherman, Texas

DFWPMA Sherman offers Byetta prescription evaluations through endocrinology and primary care providers experienced in diabetes management, metabolic disorders, and chronic disease care. These providers can assess medical eligibility and determine whether Byetta or an alternative treatment is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes type 1 and type 2 diabetes, gestational diabetes, weight management, metabolic disorders, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in diabetes and metabolic health is particularly relevant for patients seeking Byetta prescription evaluations, including individuals with type 2 diabetes and additional metabolic conditions.

Aniwelyn Tan, DNP – Primary Care

Aniwelyn Tan is a primary care provider with more than 20 years of healthcare experience, including extensive experience managing chronic medical conditions and cardiovascular health concerns.

Her clinical expertise includes diabetes management, obesity, weight management, hypertension, internal medicine, and chronic disease treatment. She provides primary care for patients ages 15 and older.

Her experience in diabetes care and metabolic health supports Byetta prescription evaluations, including assessing blood sugar control, reviewing kidney function, and developing individualized treatment plans.

Ayodya Perera, MD – Family Medicine

Dr. Ayodya Perera is a family medicine physician providing comprehensive primary care, preventive healthcare, and chronic disease management for patients ages 15 and older.

Dr. Perera’s clinical interests include diabetes management, weight management, hypertension, preventive medicine, and individualized medical treatment. The physician emphasizes shared decision-making and patient-centered healthcare.

This background in diabetes and chronic disease care is relevant to Byetta prescription evaluations, including reviewing glycemic control, kidney health, medication history, and long-term diabetes management goals.

Book an appointment online to inquire about Byetta prescription evaluations with DFWPMA’s medical providers in Sherman.

What Can a Byetta Prescription in Sherman, Texas Help With?

Byetta (exenatide) is a twice-daily injectable GLP-1 receptor agonist approved to improve blood sugar control in adults with type 2 diabetes. It increases glucose-dependent insulin secretion, reduces inappropriate glucagon release, and slows gastric emptying.

At DFWPMA Sherman, Byetta prescription evaluations address:

  • Type 2 Diabetes Management: Improving blood sugar control in eligible adults with type 2 diabetes.
  • Elevated Hemoglobin A1c: Lowering A1c levels that exceed individualized diabetes treatment goals.
  • Post-Meal Blood Sugar Control: Helping reduce glucose elevations after meals through effects on insulin, glucagon, and gastric emptying.
  • Blood Sugar Regulation: Improving glucose control through GLP-1 receptor activation.
  • Additional Diabetes Medication Needs: Evaluating Byetta when existing diabetes treatments provide insufficient glycemic control.
  • Individualized Noninsulin Diabetes Treatment: Considering Byetta as part of a comprehensive type 2 diabetes medication plan.
  • Diabetes With Additional Metabolic Conditions: Managing type 2 diabetes alongside obesity, hypertension, or high cholesterol.

Byetta improves blood sugar control by stimulating glucose-dependent insulin release, reducing glucagon secretion, and slowing gastric emptying. Its twice-daily dosing is timed before meals rather than administered once weekly.

The American Academy of Family Physicians recognizes GLP-1 receptor agonists as established noninsulin treatment options for type 2 diabetes, with medication selection based on effectiveness, safety, and individual patient needs.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Byetta is not indicated for type 1 diabetes or chronic weight management. It is not recommended for patients with severe kidney impairment or end-stage kidney disease. Important risks include pancreatitis, severe gastrointestinal reactions, dehydration-related kidney injury, and hypoglycemia when combined with certain diabetes medications.

Unlike some other GLP-1 medications, Byetta does not carry a boxed warning for medullary thyroid carcinoma or MEN2. Its specific contraindications include severe hypersensitivity to exenatide and a history of exenatide-associated drug-induced immune-mediated thrombocytopenia.

Patients seeking GLP-1 treatment primarily for obesity should discuss medications specifically approved for chronic weight management rather than Byetta.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Schedule an appointment to discuss Byetta prescription eligibility at DFWPMA Sherman.

What Byetta Prescription Services Are Available at DFWPMA Sherman?

DFWPMA Sherman provides Byetta prescription evaluations, diabetes and kidney function testing, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology and primary care providers.

Our Byetta prescription services include:

  • Initial Byetta Prescription Evaluation: Reviewing medical history, diabetes status, kidney function, and treatment eligibility.
  • Diabetes and Metabolic Testing: Checking A1c, blood glucose, kidney function, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Byetta Prescription and Treatment Planning: Prescribing Byetta when medically appropriate and available while establishing diabetes management goals.
  • Starting Dose and Titration: Adjusting twice-daily dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, kidney function, and other adverse reactions.
  • Blood Sugar and Treatment Response Monitoring: Tracking glucose control, A1c changes, and medication effectiveness.
  • Long-Term Diabetes and Metabolic Care: Managing diabetes, kidney health, cardiovascular risk factors, and related chronic conditions.
  • Alternative Diabetes Medication Evaluation: Considering other approved medications when Byetta is unsuitable or unavailable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Byetta typically starts at 5 mcg twice daily within 60 minutes before morning and evening meals, or two main meals at least six hours apart. The dose may increase to 10 mcg twice daily after one month, depending on treatment response and tolerance. Byetta should not be injected after meals.

Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention. Kidney function monitoring is particularly important in patients experiencing dehydration or existing renal impairment.

The American Academy of Family Physicians emphasizes individualized diabetes medication selection based on effectiveness, safety, comorbidities, and patient treatment goals.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Not every patient qualifies for Byetta. A medical evaluation determines whether the medication or an alternative diabetes treatment is appropriate. Byetta should not be combined with other exenatide-containing medications.

Looking for a Byetta prescription in Sherman, Texas? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.